Morning Movers 9/16: KERX, HSR, DARA, ATCO, AEZS, OMTR, ACAS Higher; IRFC, DIET, AGCO, HLCS Lower Sep 16, 2009 10:40AM

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) 60.3% HIGHER; announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the FDA for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.

Hi-Shear Technology Corporation (NYSE: HSR) 58.1% HIGHER; Chemring Group PLC entered into a conditional agreement to acquire the entire issued stock capital of for a cash consideration of $19.18 per share equating to $132 million.

DARA BioSciences, Inc. (Nasdaq: DARA) 53% HIGHER; continuing higher this morning, on heavy volume after rising 17% yesterday related to news its RN5500 study have been selected for presentation at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain to be held in San ...